PMID: 3752056Oct 1, 1986Paper

Association of low birth weight with passive smoke exposure in pregnancy

American Journal of Epidemiology
T R Martin, M B Bracken

Abstract

In a prospective study of 3,891 antenatal patients at Yale-New Haven Hospital between 1980 and 1982, one fourth (23.6%) had not smoked cigarettes during pregnancy but had been exposed to sidestream smoke for at least two hours per day. Among the nonsmokers, passive smoke exposure was significantly related to delivering a low birth weight (less than 2,500 g) newborn. This relation only occurred in term (greater than or equal to 37 weeks) deliveries. Compared with unexposed women, the relative risk of low birth weight after adjustment for confounding factors was 2.17 (95% confidence interval (CI) = 1.05-4.50). Those exposed to passive smoke delivered infants 24 g lighter on average. There was no additive effect of passive smoking on smokers themselves. Repeating the analysis on all women with term deliveries, therefore, resulted in a slightly diminished risk of low birth weight due to passive smoking of 1.52 (95% CI = 0.90-2.56). The risk of low birth weight at term due to direct cigarette smoking was 3.54 (95% CI = 1.62-7.71). Gestational age was unrelated to passive smoking, which appears to exert its effect primarily through growth retardation in term newborns.

Citations

Apr 1, 1992·British Journal of Obstetrics and Gynaecology·M MathaiL Jeyaseelan
Jun 1, 1992·Journal of Epidemiology and Community Health·S CnattingiusO Meirik
Apr 1, 1991·Paediatric and Perinatal Epidemiology·A W Read, F J Stanley
Dec 1, 1987·The American Review of Respiratory Disease·J M SametJ D Spengler
Apr 1, 1993·Paediatric and Perinatal Epidemiology·J F Rogers, W L Graves
Dec 1, 1995·Pediatric Annals·R S Byrd, C R Howard
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·H WitschiK E Pinkerton
Jan 10, 2002·Environmental Health Perspectives·Erick BoyHernán Delgado
Nov 25, 2003·Journal of Neuroscience Research·Douglas S WebberJohn Edmond
Apr 7, 2005·Environmental Health Perspectives·Changzhong ChenXiping Xu
Sep 1, 1988·Postgraduate Medical Journal·M J CampbellM Wailoo
Dec 11, 1999·Environmental Health Perspectives·D P Misra, R H Nguyen
Feb 1, 1993·American Journal of Public Health·J Zhang, J M Ratcliffe
May 20, 1999·Human & Experimental Toxicology·W HankeW Sobala
Oct 13, 2006·Environmental Health Perspectives·Thaddeus MillerFrederica Perera
Feb 17, 2007·Clinical Obstetrics and Gynecology·Alejandro A Nava-Ocampo, Gideon Koren
Jul 1, 1998·Environmental Health and Preventive Medicine·N YoshiokaT Ohkado
Jan 18, 2011·Hematology·Gideon Koren, Michael Lishner
May 20, 2014·American Journal of Epidemiology·Jie QiuYawei Zhang
Mar 19, 2016·Maternal and Child Health Journal·Karla S Bartholomew, Rahi Abouk
Aug 1, 1991·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M A Wakefield, W R Jones
Jun 1, 1991·Journal of Epidemiology and Community Health·H OgawaM Matsubara
Feb 1, 1990·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M MathaiA M Weindling
May 20, 1999·Human & Experimental Toxicology·J Klein, G Koren
Oct 17, 1998·American Journal of Public Health·E Dejin-KarlssonK Marsal
Dec 1, 1988·British Journal of Obstetrics and Gynaecology·L MeyerJ Dreyfus
Feb 1, 1995·Acta Paediatrica·J M RoquerR Jiménez
Jan 1, 1987·Yearbook of Physical Anthropology·R Martorell, T Gonzalez-cossio
Dec 1, 1995·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·D E Stewart, D L Streiner
Jun 28, 2002·Journal of Exposure Analysis and Environmental Epidemiology·Farla Lynn KaufmanJohn Thomas Bernert
Aug 28, 2007·International Journal of Occupational and Environmental Health·Wieslaw JedrychowskiFrederica Perera
Mar 7, 2014·European Heart Journal·Edmund M T Lau, David S Celermajer
Feb 9, 2017·International Archives of Occupational and Environmental Health·W A JedrychowskiF P Perera
Dec 1, 1995·The Japanese Journal of Human Genetics·P YuanY Kuroki
Nov 15, 2000·Journal of Psychosomatic Obstetrics and Gynaecology·D Da CostaW Brender

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.